IMMUNE AND NONIMMUNE BASES OF RENAL DISEASE
肾病的免疫和非免疫基础
基本信息
- 批准号:6849715
- 负责人:
- 金额:$ 35.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-12-01 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Over the last 15 years, the PI's effort to investigate the 'immune
and non-immune mechanisms of renal diseases' has progressively focused on the
role of the renin-angiotensin system (RAS). Through animal and human studies,
the PT has documented that angiotensin II produces damages to the kidney
through several previously recognized and unrecognized biological properties.
In an attempt to pinpoint the specific biological events involved in the
actions of angiotensin II, the PI took the step to completely and selectively
inactivate the several genes comprising RAS, i.e., the genes of its precursor,
metabolizing enzyme and receptors.
From the early stage of analyzing the produced mutants, however, the PI began
to realize that RAS has an important physiological role for the ontogeny of the
kidney and urinary tract, and that, in fact, a defect in this system, can cause
diseases of the kidney and urinary tract. A mutation in one of those genes has
even been linked to a special group of common (1 / 100 births) congenital human
diseases, which are collectively called 'congenital anomalies of the kidney and
urinary tract'. Taking this newly arrived opportunity, the PI now plans to
delineate the ontogeny of this disease entity, and at the same time, to shed
light into the physiologic role of RAS in normal kidney and urinary tract
development.
在过去的15年里,PI致力于调查“免疫”
和非免疫机制的肾脏疾病“已逐步集中在
肾素-血管紧张素系统(RAS)。通过动物和人类研究,
PT记录了血管紧张素II对肾脏的损害
通过几个以前认识到和未认识到的生物学特性。
在试图确定特定的生物学事件涉及的
血管紧张素II的作用,PI采取步骤,完全和选择性地
包括RAS的几个基因,即,其前体的基因,
代谢酶和受体。
然而,从分析产生的突变体的早期阶段开始,PI开始
认识到RAS在个体发育中具有重要的生理作用,
肾脏和泌尿道,事实上,这个系统的缺陷,会导致
肾脏和泌尿道疾病。其中一个基因的突变
甚至与一组特殊的常见(1 / 100出生)先天性人类
这些疾病统称为“先天性肾脏异常”,
泌尿道利用这个新的机会,PI现在计划
描述这种疾病实体的个体发育,同时,
阐明RAS在正常肾脏和泌尿道中的生理作用
发展
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of peritubular capillary forces in the renal action of carbonic anhydrase inhibitor.
肾小管周围毛细血管力在碳酸酐酶抑制剂肾作用中的作用。
- DOI:10.1038/ki.1986.262
- 发表时间:1986
- 期刊:
- 影响因子:19.6
- 作者:Ichikawa,I;Kon,V
- 通讯作者:Kon,V
Effect of diet, age and sex on the renal response to immune injury in the rat.
饮食、年龄和性别对大鼠肾脏对免疫损伤反应的影响。
- DOI:10.1038/ki.1988.34
- 发表时间:1988
- 期刊:
- 影响因子:19.6
- 作者:Yared,A;Miyazawa,H;Purkerson,ML;Klahr,S;Salant,DJ;Ichikawa,I
- 通讯作者:Ichikawa,I
In vivo influence of prostaglandin I2 on systemic and renal circulation in the rat.
前列腺素 I2 对大鼠全身和肾循环的体内影响。
- DOI:10.1161/01.hyp.7.6.867
- 发表时间:1985
- 期刊:
- 影响因子:0
- 作者:Yoshioka,T;Yared,A;Miyazawa,H;Ichikawa,I
- 通讯作者:Ichikawa,I
Role for angiotensin II in an overt functional proteinuria.
血管紧张素 II 在明显的功能性蛋白尿中的作用。
- DOI:10.1038/ki.1986.219
- 发表时间:1986
- 期刊:
- 影响因子:19.6
- 作者:Yoshioka,T;Mitarai,T;Kon,V;Deen,WM;Rennke,HG;Ichikawa,I
- 通讯作者:Ichikawa,I
Interglomerular heterogeneity of filtration fraction among superficial nephrons: fact or artifact.
浅表肾单位滤过分数的肾小球间异质性:事实或伪影。
- DOI:10.1038/ki.1986.71
- 发表时间:1986
- 期刊:
- 影响因子:19.6
- 作者:Hughes,ML;Ichikawa,I
- 通讯作者:Ichikawa,I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IEKUNI ICHIKAWA其他文献
IEKUNI ICHIKAWA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IEKUNI ICHIKAWA', 18)}}的其他基金
相似海外基金
Exploratory Efficacy-Evaluation Study of Angiotensin Receptor-Neprilysin Inhibitor in patients with dialysis
血管紧张素受体脑啡肽酶抑制剂在透析患者中的探索性疗效评价研究
- 批准号:
21K16191 - 财政年份:2021
- 资助金额:
$ 35.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
慢性肾脏病的个体化血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂治疗
- 批准号:
10313873 - 财政年份:2021
- 资助金额:
$ 35.86万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10469311 - 财政年份:2020
- 资助金额:
$ 35.86万 - 项目类别:
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis - a Randomized Controlled Trial
血管紧张素受体阻滞剂对主动脉瓣狭窄的影响 - 一项随机对照试验
- 批准号:
433568 - 财政年份:2020
- 资助金额:
$ 35.86万 - 项目类别:
Operating Grants
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10649490 - 财政年份:2020
- 资助金额:
$ 35.86万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10210299 - 财政年份:2020
- 资助金额:
$ 35.86万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10065083 - 财政年份:2020
- 资助金额:
$ 35.86万 - 项目类别:
Mechanism of suppressive effects for atherosclerosis by Angiotensin Receptor-Neprilysin Inhibitor
血管紧张素受体脑啡肽酶抑制剂抑制动脉粥样硬化的机制
- 批准号:
19K17618 - 财政年份:2019
- 资助金额:
$ 35.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathophysiological significance of angiotensin receptor-binding protein in leucocytes and immune cells
白细胞和免疫细胞中血管紧张素受体结合蛋白的病理生理意义
- 批准号:
19K17575 - 财政年份:2019
- 资助金额:
$ 35.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
AgRP 神经元中血管紧张素受体 G 蛋白信号转换在心脏代谢控制中的作用
- 批准号:
10658260 - 财政年份:2017
- 资助金额:
$ 35.86万 - 项目类别: